FindTrial
Sign In

Asymptomatic gout in patients with severe renal failure measured by Dual Energy CT (DECT) and Ultrasonography.

Asymptomatic gout in patients with severe renal failure measured by Dual Energy CT (DECT) and Ultrasonography. - GoUT, Tophi, Renal failure (GUTTeR)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43979
Enrollment
Unknown
Registered
2015-08-05
Start date
2015-08-18
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout tophi urate deposits

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - eGFR 6months) - 18 years or older

Exclusion criteria

Exclusion criteria: - Poor knowledge of the Dutch language - No written informed consent - Pregnancy; - Dialysis-dependency Only for a selection of the patients: - history of gout or history or attacks of arthritis - Use of urate lowering drugs (iallopurinol, desuric and adenuric)

Design outcomes

Primary

MeasureTime frame
The percentage of patients with MSU deposits on - Dual Energy CT-scan - Ultrasound - Physical examination The percentage of patients with erosions on - conventional x-ray—

Secondary

MeasureTime frame
Difference between patient with MSU deposits on examination in: - Quality of life measured by the HAQ and SF-36 - Uric acid levels in serum—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)